MedPath

Pitavastatin

Pitavastatin Tablets Rx only These highlights do not include all the information needed to use PITAVASTATIN TABLETS safely and effectively. See full prescribing information for PITAVASTATIN TABLETS. Initial U.S. Approval: 2009

Approved
Approval ID

0f11ee80-871e-4f13-e063-6394a90af19d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 16, 2024

Manufacturers
FDA

AvKARE

DUNS: 796560394

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

pitavastatin calcium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42291-906
Application NumberANDA205932
Product Classification
M
Marketing Category
C73584
G
Generic Name
pitavastatin calcium
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 16, 2024
FDA Product Classification

INGREDIENTS (11)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
PITAVASTATIN CALCIUMActive
Quantity: 2.09 mg in 1 1
Code: IYD54XEG3W
Classification: ACTIM
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71G
Classification: IACT

pitavastatin calcium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42291-905
Application NumberANDA205932
Product Classification
M
Marketing Category
C73584
G
Generic Name
pitavastatin calcium
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 16, 2024
FDA Product Classification

INGREDIENTS (11)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71G
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
PITAVASTATIN CALCIUMActive
Quantity: 1.045 mg in 1 1
Code: IYD54XEG3W
Classification: ACTIM
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT

pitavastatin calcium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42291-907
Application NumberANDA205932
Product Classification
M
Marketing Category
C73584
G
Generic Name
pitavastatin calcium
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 16, 2024
FDA Product Classification

INGREDIENTS (11)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71G
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
PITAVASTATIN CALCIUMActive
Quantity: 4.18 mg in 1 1
Code: IYD54XEG3W
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pitavastatin - FDA Drug Approval Details